Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call NASDAQ | TSX

Aurora Cannabis to Host Third

Quarter 2026 Investor Conference Call

21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading

global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter

2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results

for the third quarter 2026 before the opening of markets that same day.

Miguel Martin, Executive

Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer

period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under

About Aurora Cannabis

Aurora is opening the

world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in

Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use

brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf,

CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has

a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and

innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the

medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow

us on X and LinkedIn.

Aurora's common shares

trade on the NASDAQ and TSX under the symbol "ACB".

This news release includes

statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking

statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",

"project", "intend", "believe", "anticipate", "estimate", "may", "will",

"potential", "proposed" and other similar words, or statements that certain events or conditions "may"

or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding

the timing for the release of the Company's fiscal 2026 Q3 financial statements and the conference call to discuss the results.

These forward-looking

statements are only predictions. Forward looking information or statements contained in this news release have been developed based on

assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements

include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis

and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements

are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances

could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from

those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential

new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability

to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality

of our products, customer experience and retention, the development of third party government and non-government consumer sales channels,

management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and

expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only

in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general

impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities,

competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health

crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information

from dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer

profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the

list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its

results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements

and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention

or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,

except as expressly required by applicable securities law.

SOURCE Aurora Cannabis

View original content

to download multimedia: http://www.newswire.ca/en/releases/archive/January2026/21/c3366.html

For further information: For Media:

Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com

CNW 16:35e 21-JAN-26